{{header-clinical-trials-navigation}}
{{footer-clinical-trials-navigation}}
A Phase 2 Comparison Study of 68Ga-PSMA-HBED-CC Positron Emission Tomography (PET)/CT or PET/MRI Imaging to Magnetic Resonance Imaging (MRI) Alone in Men With Prostate Cancer
Condition: Prostate Cancer
Study Type: Interventional
Clinical Trials Identifier NCT 8-digits: NCT03439033
Sponsor: Weill Medical College of Cornell University
Phase: Phase 2
Eligibility:
- Age: minimum 21 Years maximum N/A
- Gender: Male
Exclusion Criteria:
- Clinical and/or technical factors that would compromise statistical analysis of the PET and/or MRI.
- If part of PET/MRI cohort and patient cohort 3 or 5, subject does not plan to have a prescribed abdomen and pelvis MRI
- If part of PET/MRI cohort and patient cohort 1, 2 or 4, subject does not plan to have a prescribed pelvis MRI
- If part of PET/CT cohort and patient cohort 3 or 5, subject does not have previous MR imaging of abdomen and pelvis
- If part of PET/CT cohort and patient cohort 1, 2 or 4, subject does not have previous MR imaging of pelvis
- If part of PET/CT cohort, investigator review determines that previous MR images do not meet institutional quality standards
- If part of PET/MRI cohort, contraindications to MRI
- Contraindications to PSMA IV administration
- Other unspecified reasons that, in the opinion of investigators, make the subject unsuitable for enrollment
View trial on ClinicalTrials.gov
{{footer-clinical-trials-navigation}}